See more : Deep-South Resources Inc. (DSMTF) Income Statement Analysis – Financial Results
Complete financial analysis of Ventas, Inc. (VTR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ventas, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- ViewRay, Inc. (VRAY) Income Statement Analysis – Financial Results
- Eco Oro Minerals Corp. (EOM.CN) Income Statement Analysis – Financial Results
- Legato Merger Corp. (LEGOW) Income Statement Analysis – Financial Results
- Shenzhen H&T Intelligent Control Co., Ltd. (002402.SZ) Income Statement Analysis – Financial Results
- Saturn Oil & Gas Inc. (SOIL.TO) Income Statement Analysis – Financial Results
Ventas, Inc. (VTR)
About Ventas, Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.50B | 4.13B | 3.83B | 3.80B | 3.87B | 3.75B | 3.57B | 3.44B | 3.29B | 3.08B | 2.81B | 2.49B | 1.76B | 1.02B | 931.58M | 929.77M | 771.79M | 418.45M | 324.72M | 232.91M | 205.00M | 196.70M | 204.58M | 242.32M | 233.25M | 149.93M | 3.12B | 2.58B | 2.32B |
| Cost of Revenue | 3.73B | 2.28B | 2.09B | 1.94B | 1.81B | 1.69B | 1.49B | 1.44B | 1.41B | 1.21B | 1.12B | 979.23M | 678.64M | 325.47M | 302.81M | 306.94M | 198.13M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 770.72M | 1.85B | 1.74B | 1.86B | 2.06B | 2.05B | 2.09B | 2.00B | 1.88B | 1.86B | 1.69B | 1.51B | 1.09B | 691.40M | 628.76M | 622.82M | 573.67M | 418.45M | 324.72M | 232.91M | 205.00M | 196.70M | 204.58M | 242.32M | 233.25M | 149.93M | 3.12B | 2.58B | 2.32B |
| Gross Profit Ratio | 17.14% | 44.71% | 45.44% | 48.89% | 53.25% | 54.85% | 58.41% | 58.12% | 57.09% | 60.59% | 60.22% | 60.60% | 61.55% | 67.99% | 67.49% | 66.99% | 74.33% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | -0.01 | 0.02 | 0.09 | 0.10 | 0.10 | 0.36 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 148.88M | 144.87M | 129.76M | 130.16M | 166.00M | 151.98M | 135.49M | 126.88M | 128.04M | 121.75M | 115.11M | 98.80M | 0.00 | 0.00 | 38.83M | 36.43M | 36.43M | 26.14M | 23.10M | 16.92M | 12.72M | 9.76M | 10.24M | 9.69M | 7.77M | 5.70M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 148.88M | 144.87M | 129.76M | 130.16M | 166.00M | 151.98M | 135.49M | 126.88M | 128.04M | 121.75M | 115.11M | 98.80M | 74.54M | 49.83M | 38.83M | 40.65M | 36.43M | 26.14M | 23.10M | 16.92M | 12.72M | 9.76M | 10.24M | 9.69M | 7.77M | 5.70M | 0.00 | 1.49B | 0.00 |
| Other Expenses | 0.00 | 1.22B | 1.19B | 1.13B | 1.05B | -66.77M | -20.05M | -9.99M | -17.96M | -38.93M | -18.73M | -6.96M | 0.00 | 0.00 | 263.98M | 161.70M | 161.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.94B | 1.36B | 1.32B | 1.26B | 1.21B | 1.07B | 1.02B | 1.03B | 1.02B | 948.66M | 837.07M | 824.78M | 365.13M | 265.22M | 244.49M | 274.35M | 246.12M | 154.55M | 100.61M | 68.50M | 66.64M | 69.49M | 63.27M | 64.03M | 100.66M | 37.97M | 2.79B | 2.53B | 2.32B |
| Cost & Expenses | 3.83B | 3.65B | 3.41B | 3.20B | 3.02B | 2.76B | 2.51B | 2.47B | 2.43B | 2.16B | 1.96B | 1.80B | 1.04B | 590.69M | 547.30M | 581.30M | 444.24M | 154.55M | 100.61M | 68.50M | 66.64M | 69.49M | 63.27M | 64.03M | 100.66M | 37.97M | 2.79B | 2.53B | 2.32B |
| Interest Income | 0.00 | 463.92M | 425.28M | 7.61M | 10.98M | 24.89M | 6.03M | 876.00K | 1.05M | 4.27M | 2.05M | 1.11M | 0.00 | 0.00 | 842.00K | 2.96M | 2.99M | 2.89M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 574.11M | 467.56M | 440.09M | 469.54M | 451.66M | 442.50M | 448.20M | 419.74M | 367.11M | 376.84M | 334.48M | 293.40M | 236.81M | 178.86M | 176.99M | 203.18M | 204.22M | 136.54M | 0.00 | 0.00 | 80.20M | 86.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.17B | 3.60B | 3.22B | 3.05B | 2.87B | 2.80B | 2.50B | 2.44B | 979.11M | 828.16M | 753.14M | 724.83M | 459.70M | 214.71M | 207.61M | 235.72M | 237.50M | 119.65M | 88.00M | 54.34M | 39.51M | 41.25M | 40.37M | 43.60M | 42.80M | 29.05M | 123.87M | 99.53M | 89.48M |
| EBITDA | 1.83B | 1.65B | 1.60B | 1.72B | 1.93B | 1.80B | 1.95B | 1.95B | 1.81B | 1.70B | 1.59B | 1.42B | 1.00B | 609.50M | 578.87M | 584.19M | 549.60M | 399.04M | 312.11M | 212.99M | 159.19M | 171.07M | 185.09M | 191.26M | 177.93M | 141.01M | 451.07M | 147.54M | 97.84M |
| EBITDA Ratio | 40.71% | 40.00% | 41.91% | 45.40% | 49.95% | 48.04% | 54.49% | 54.57% | 55.19% | 55.40% | 56.54% | 57.07% | 66.91% | 62.96% | 63.54% | 62.83% | 73.21% | 91.96% | 96.60% | 66.25% | 77.65% | 86.97% | 90.47% | 151.09% | 76.29% | 94.05% | 14.48% | 5.72% | 4.21% |
| Operating Income | 665.12M | 454.08M | 389.30M | 592.58M | 865.76M | 861.09M | 622.09M | 556.79M | 834.72M | 875.84M | 835.80M | 693.64M | 51.17M | 52.22M | 208.12M | 145.29M | 126.32M | 125.42M | 100.22M | 87.10M | 119.68M | 129.82M | 144.72M | 322.51M | 135.13M | 111.96M | 327.20M | 48.01M | 8.36M |
| Operating Income Ratio | 14.79% | 11.00% | 10.17% | 15.61% | 22.36% | 22.99% | 17.41% | 16.17% | 25.40% | 28.48% | 29.74% | 27.91% | 2.90% | 5.13% | 22.34% | 15.63% | 16.37% | 29.97% | 30.86% | 37.39% | 58.38% | 66.00% | 70.74% | 133.09% | 57.94% | 74.68% | 10.50% | 1.86% | 0.36% |
| Total Other Income/Expenses | -704.95M | -511.94M | -1.55B | -1.35B | -618.83M | -569.59M | -644.18M | -354.58M | -118.78M | -8.73M | -11.83M | -79.43M | -210.39M | -202.44M | -190.06M | -185.42M | -174.43M | -136.54M | -103.21M | -42.85M | -47.89M | -79.14M | -163.98M | -252.50M | -247.28M | -124.73M | -102.74M | 35.18M | 24.00M |
| Income Before Tax | -39.84M | -57.86M | 61.39M | 344.65M | 382.99M | 376.04M | 584.15M | 522.87M | 350.26M | 448.38M | 478.48M | 298.27M | 330.44M | 227.13M | 194.27M | 145.29M | 120.35M | 130.58M | 120.90M | 100.17M | 96.73M | 50.69M | 54.28M | -61.25M | 42.54M | 55.96M | 224.47M | 83.18M | 32.36M |
| Income Before Tax Ratio | -0.89% | -1.40% | 1.60% | 9.08% | 9.89% | 10.04% | 16.34% | 15.18% | 10.66% | 14.58% | 17.03% | 12.00% | 18.72% | 22.34% | 20.85% | 15.63% | 15.59% | 31.21% | 37.23% | 43.01% | 47.19% | 25.77% | 26.53% | -25.27% | 18.24% | 37.32% | 7.20% | 3.23% | 1.39% |
| Income Tax Expense | -9.54M | -16.93M | 4.83M | -96.53M | -56.31M | -39.95M | -59.80M | -31.34M | -39.28M | -8.73M | -11.83M | -6.28M | -31.14M | 5.20M | -1.72M | -15.89M | -28.04M | 132.47M | 93.53M | 43.52M | -22.91M | -2.20M | 2.69M | 243.75M | 91.30M | 21.15M | 89.34M | 35.18M | 24.00M |
| Net Income | -40.97M | -40.93M | 49.01M | 439.15M | 433.02M | 409.47M | 1.36B | 649.23M | 417.84M | 475.77M | 453.51M | 362.80M | 364.49M | 246.17M | 266.50M | 226.29M | 282.32M | 131.43M | 130.58M | 120.90M | 162.75M | 65.71M | 50.57M | -65.45M | 42.54M | 26.76M | 130.93M | 48.01M | -14.89M |
| Net Income Ratio | -0.91% | -0.99% | 1.28% | 11.57% | 11.18% | 10.93% | 37.95% | 18.85% | 12.71% | 15.47% | 16.14% | 14.60% | 20.65% | 24.21% | 28.61% | 24.34% | 36.58% | 31.41% | 40.21% | 51.91% | 79.39% | 33.40% | 24.72% | -27.01% | 18.24% | 17.85% | 4.20% | 1.86% | -0.64% |
| EPS | -0.10 | -0.11 | 0.13 | 1.18 | 1.18 | 1.15 | 3.82 | 1.88 | 1.26 | 1.62 | 1.55 | 1.24 | 1.60 | 1.57 | 1.75 | 1.62 | 2.26 | 1.26 | 1.37 | 1.45 | 2.05 | 0.95 | 0.74 | -0.96 | 0.63 | 0.39 | 1.90 | 0.68 | -0.24 |
| EPS Diluted | -0.10 | -0.11 | 0.13 | 1.17 | 1.17 | 1.14 | 3.78 | 1.86 | 1.25 | 1.60 | 1.54 | 1.23 | 1.58 | 1.56 | 1.74 | 1.62 | 2.25 | 1.25 | 1.36 | 1.43 | 2.03 | 0.93 | 0.73 | -0.96 | 0.63 | 0.39 | 1.86 | 0.68 | -0.21 |
| Weighted Avg Shares Out | 401.81M | 373.37M | 382.79M | 373.37M | 365.98M | 356.27M | 355.33M | 344.70M | 330.31M | 294.18M | 292.65M | 292.06M | 228.45M | 156.61M | 152.57M | 139.57M | 122.60M | 104.21M | 95.04M | 83.49M | 79.34M | 69.34M | 68.41M | 68.01M | 67.75M | 67.68M | 68.94M | 69.70M | 62.32M |
| Weighted Avg Shares Out (Dil) | 401.81M | 373.37M | 386.30M | 376.50M | 369.89M | 359.30M | 358.57M | 348.39M | 334.01M | 296.68M | 295.11M | 294.49M | 230.79M | 157.66M | 152.76M | 139.91M | 123.01M | 104.73M | 95.78M | 84.35M | 80.09M | 70.29M | 69.36M | 68.13M | 67.99M | 68.61M | 70.36M | 70.70M | 71.97M |
Ventas, Inc. (VTR) Q3 2024 Earnings Call Transcript
Ventas, Inc. (VTR) Q3 2024 Earnings Call Transcript
Ventas' Q3 FFO Meet Estimates on Higher Same-Store NOI, View Raised
VTR's Q3 results reflect a year-over-year rise in revenues. The total property same-store NOI improves on strong performance across the business segments.
Here's What Key Metrics Tell Us About Ventas (VTR) Q3 Earnings
Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ventas (VTR) Q3 FFO Match Estimates
Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.80 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.75 per share a year ago.
Healthcare REIT Ventas raises annual FFO per share forecast
Healthcare REIT Ventas slightly raised the lower end of its annual funds from operations (FFO) forecast on Wednesday, expecting continued strong performance from its assisted living and senior housing properties.
Ventas Reports 2024 Third Quarter Results
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the third quarter ended September 30, 2024. CEO Remarks “Ventas delivered another strong quarter executing on our focused strategy to capture the unprecedented multiyear growth opportunity in...
Stay Ahead of the Game With Ventas (VTR) Q3 Earnings: Wall Street's Insights on Key Metrics
Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
These REITs Trade At Discounts, But Should They?
There are substantial valuation gaps among REIT sectors, with some justified by fundamentals and others representing mispricing, providing investment opportunities in undervalued sectors. Hotels and office REITs face significant challenges, including erratic earnings, high costs, and post-COVID demand shifts, making...
What's in the Offing for Ventas Stock This Earnings Season?
VTR's Q3 earnings are likely to have benefited from favorable SHOP operating trends, healthy demand for life-science real estate assets and accretive investments.
Healthpeak's Q3 FFO Beats Estimates, Same-Store NOI Rises
DOC's Q3 FFO tops estimates. Results reflect a year-over-year rise in revenues and total merger-combined same-store cash (adjusted) NOI.
Source: https://incomestatements.info
Category: Stock Reports